R&D Views & Analysis | pharmaphorum

Views & Analysis

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

(781)NIHR-2nd-Webinar-Image-16x9-Text-v3

Increasing patient engagement with UK clinical trials

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of researc

Views & Analysis

Towards a new understanding of cardiovascular risk in diabet...

A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes patients by better predicting t

Views & Analysis

We should allow ourselves to be #pharmaproud

In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present.

Views & Analysis

Pharma's response to COVID-19: Lilly and diabetes care

As part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader of Eli Lilly and Company's diabetes business unit in Northern Europe, tells pharmaph

Views & Analysis

Are rapid progress and patient engagement mutually exclusive...

COVID-19 has sparked a flurry of research and discoveries are being made at an unprecedented rate – but patient participation cannot and should not be left behind in the rush, say leading v

Views & Analysis

The ‘failure’ of clinical trials in the search for a new effective treatment for a global pandemic

The ‘failure’ of clinical trials in the search for COVID-19 ...

Professor Jean-Pierre Boissel outlines the urgent need for disruptive R&D approaches that can tackle the search for COVID-19 treatments more effectively.

Increasing patient engagement with UK clinical trials

Towards a new understanding of cardiovascular risk in diabet...

We should allow ourselves to be #pharmaproud

Pharma's response to COVID-19: Lilly and diabetes care

Are rapid progress and patient engagement mutually exclusive...

The ‘failure’ of clinical trials in the search for COVID-19 ...

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks